Germline-targeting elicits cross-neutralizing, H3-dominated HIV CD4bs antibodies
Eliciting broadly neutralizing antibodies (bnAbs) remains central in HIV vaccine design, yet vaccines have not induced bnAbs in humans and have had limited success in animal models. A key challenge is converting precursor B-cell recognition into maturation toward conserved epitopes on HIV Env. Here, we show that a three-shot germline-targeting regimen reproducibly activates and matures CDRH3-dominated CD4-binding-site (CD4bs) antibody precursors in CH103-lineage knock-in mice, inducing strong autologous tier-2 and selected heterologous cross-neutralizing serum responses, as well as monoclonal antibodies with tier-2 cross-neutralizing activity. This response is enabled by native-like, membrane-embedded Env arrays on liposomes bearing limited germline-targeting mutations, including the N197D glycan-site mutation, that promote B-cell activation, CH103-class somatic hypermutation, and quaternary Env-antibody recognition. Cryo-electron microscopy of representative antibodies shows recognition of a quaternary CD4bs epitope involving adjacent Env protomers, linking serum neutralization to structural maturation. Env variants that bind multiple CD4bs precursor classes further point to a membrane-Env strategy for multi-lineage germline targeting.
Authors
- Mariane B. Melo (ORCID: https://orcid.org/0000-0002-0409-2454)
- Miyo Ota (ORCID: https://orcid.org/0000-0003-1036-699X)
- David C. Montefiori (ORCID: https://orcid.org/0000-0003-0856-6319)
- Jinsong Zhang (ORCID: https://orcid.org/0000-0002-2195-2997)
- Laurent K. Verkoczy (ORCID: https://orcid.org/0000-0001-7497-6645)
- Christine Shamblin
- Spencer Brown
- Amanda Eaton (ORCID: https://orcid.org/0000-0003-3064-2947)
- Nelson Wu
- Gabriel Ozorowski (ORCID: https://orcid.org/0000-0002-9695-8138)
- Max Crispin (ORCID: https://orcid.org/0000-0002-1072-2694)
- Christopher A. Cottrell (ORCID: https://orcid.org/0000-0002-3364-3083)
- Barton F. Haynes (ORCID: https://orcid.org/0000-0002-7643-9023)
- Daniel P. Leaman (ORCID: https://orcid.org/0000-0002-8490-1126)
- Grace Gibson (ORCID: https://orcid.org/0009-0002-8312-2953)
- Michael B. Zwick (ORCID: https://orcid.org/0000-0002-0885-2502)
- Celia C. LaBranche (ORCID: https://orcid.org/0000-0002-6653-6655)
- Angel Gandarilla
- Dalton C. Karlinsey (ORCID: https://orcid.org/0009-0004-1786-905X)
- Andrew B. Ward (ORCID: https://orcid.org/0000-0001-7153-3769)
- Armando Stano
- Joel D. Allen (ORCID: https://orcid.org/0000-0003-2547-968X)
- Alex LaBranche
- Darrell J. Irvine (ORCID: https://orcid.org/0000-0002-8637-1405)
- Bing Wang (ORCID: https://orcid.org/0000-0003-3662-7625)
- Yajing Chen (ORCID: https://orcid.org/0000-0001-8330-3901)
- Takayuki Ota (ORCID: https://orcid.org/0009-0007-4286-4156)
- Agnes A. Walsh
- Adam J. Ferguson (ORCID: https://orcid.org/0009-0003-2589-7424)
- Amanda Powell
- Xuan Feldman
- Daniel Sands
- Mark Ochoa
- Daniel Ryan
Institutions
- Scripps Research Institute (US)
- Duke University (US)
- Duke Medical Center (US)
- University of Southampton (GB)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-19
- DOI
- https://doi.org/10.21203/rs.3.rs-10073252/v1
- Primary Topic
- HIV Research and Treatment
- Type
- preprint